News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
745,247 Results
Type
Article (44096)
Company Profile (468)
Press Release (700665)
Multimedia
Podcasts (139)
Webinars (23)
Section
Business (209482)
Career Advice (2046)
Deals (36201)
Drug Delivery (137)
Drug Development (84155)
Employer Resources (174)
FDA (16782)
Job Trends (15217)
News (354629)
Policy (33317)
Tag
2027 BioCapital Elite (1)
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (4)
Academia (2682)
Accelerated approval (48)
Adcomms (29)
Allergies (172)
Alliances (51118)
ALS (210)
Alzheimer's disease (1824)
Antibody-drug conjugate (ADC) (453)
Approvals (17105)
Artificial intelligence (659)
Autoimmune disease (259)
Automation (52)
Bankruptcy (374)
Best Places to Work (11840)
BIOSECURE Act (20)
Biosimilars (219)
Biotechnology (330)
Bladder cancer (188)
Brain cancer (72)
Breast cancer (728)
Cancer (5764)
Cardiovascular disease (476)
Career advice (1737)
Career pathing (43)
CAR-T (328)
CDC (56)
Celiac Disease (2)
Cell therapy (880)
Cervical cancer (45)
Clinical research (72496)
Collaboration (2101)
Company closure (4)
Compensation (1353)
Complete response letters (88)
COVID-19 (2797)
CRISPR (112)
C-suite (1100)
Cystic fibrosis (159)
Data (7599)
Decentralized trials (3)
Denatured (44)
Depression (169)
Dermatology (72)
Diabetes (570)
Diagnostics (6949)
Digital health (54)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (325)
Drug pricing (209)
Drug shortages (32)
Duchenne muscular dystrophy (290)
Earnings (92600)
Editorial (68)
Employer branding (21)
Employer resources (153)
Events (122746)
Executive appointments (1092)
FDA (20416)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (34)
Funding (1741)
Gene editing (244)
Generative AI (56)
Gene therapy (739)
GLP-1 (1084)
Government (4820)
Grass and pollen (6)
Guidances (404)
Healthcare (19307)
HIV (79)
Huntington's disease (54)
IgA nephropathy (97)
Immunology and inflammation (309)
Immuno-oncology (93)
Indications (171)
Infectious disease (3136)
Inflammatory bowel disease (216)
Inflation Reduction Act (17)
Influenza (138)
Intellectual property (283)
Interviews (317)
IPO (16946)
IRA (53)
Job creations (3717)
Job search strategy (1442)
JPM (67)
Kidney cancer (18)
Labor market (96)
Layoffs (593)
Leadership (39)
Legal (8031)
Liver cancer (101)
Longevity (31)
Lung cancer (769)
Lymphoma (425)
Machine learning (59)
Management (59)
Manufacturing (1003)
MASH (187)
Medical device (14052)
Medtech (14139)
Mergers & acquisitions (20460)
Metabolic disorders (1509)
mRNA (216)
Multiple sclerosis (186)
NASH (20)
Neurodegenerative disease (420)
Neuropsychiatric disorders (110)
Neuroscience (3349)
Neurotech (1)
NextGen: Class of 2026 (6773)
Non-profit (4599)
Now hiring (75)
Obesity (722)
Opinion (309)
Ovarian cancer (209)
Pain (250)
Pancreatic cancer (290)
Parkinson's disease (368)
Partnered (34)
Patents (575)
Patient recruitment (647)
Peanut (62)
People (60894)
Pharmaceutical (80)
Pharmacy benefit managers (33)
Phase 1 (22825)
Phase 2 (31976)
Phase 3 (23606)
Pipeline (7853)
Policy (324)
Postmarket research (2605)
Preclinical (9774)
Press Release (67)
Prostate cancer (293)
Psychedelics (61)
Radiopharmaceuticals (338)
Rare diseases (1098)
Real estate (6073)
Recruiting (71)
Regulatory (25755)
Reports (55)
Research institute (2511)
Resumes & cover letters (356)
Rett syndrome (35)
RNA editing (24)
RSV (88)
Schizophrenia (179)
Series A (293)
Series B (219)
Service/supplier (11)
Sickle cell disease (118)
Special edition (27)
Spinal muscular atrophy (170)
Sponsored (48)
Startups (3826)
State (2)
Stomach cancer (19)
Supply chain (129)
Tariffs (88)
The Weekly (92)
Vaccines (1108)
Venture capital (110)
Weight loss (471)
Women's health (123)
Worklife (21)
Date
Today (153)
Last 7 days (680)
Last 30 days (2775)
Last 365 days (31159)
2026 (10319)
2025 (31070)
2024 (36299)
2023 (41024)
2022 (52295)
2021 (56775)
2020 (54927)
2019 (47425)
2018 (35701)
2017 (33033)
2016 (32355)
2015 (38402)
2014 (32194)
2013 (27114)
2012 (29231)
2011 (29873)
2010 (28000)
Location
Africa (758)
Alabama (97)
Alaska (7)
Arizona (350)
Arkansas (16)
Asia (41083)
Australia (6841)
California (12938)
Canada (3669)
China (1335)
Colorado (557)
Connecticut (569)
Delaware (386)
Europe (90332)
Florida (1917)
Georgia (414)
Hawaii (3)
Idaho (62)
Illinois (1039)
India (89)
Indiana (587)
Iowa (25)
Japan (520)
Kansas (133)
Kentucky (49)
Louisiana (40)
Maine (75)
Maryland (1550)
Massachusetts (9346)
Michigan (355)
Minnesota (706)
Mississippi (6)
Missouri (145)
Montana (35)
Nebraska (29)
Nevada (138)
New Hampshire (89)
New Jersey (3433)
New Mexico (31)
New York (3390)
North Carolina (1698)
North Dakota (9)
Northern California (6423)
Ohio (381)
Oklahoma (23)
Oregon (44)
Pennsylvania (2592)
Puerto Rico (28)
Rhode Island (51)
South America (1126)
South Carolina (85)
South Dakota (2)
Southern California (5072)
Tennessee (204)
Texas (2036)
United States (45896)
Utah (384)
Vermont (1)
Virginia (309)
Washington D.C. (81)
Washington State (1062)
West Virginia (4)
Wisconsin (127)
Wyoming (2)
745,247 Results for "ascend therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Bambusa Therapeutics Presented Positive Results from the Phase 1 Multiple Ascending Dose Trial of BBT001 at the 2026 American Academy of Dermatology (AAD) Annual Meeting
April 2, 2026
·
5 min read
Press Releases
SCYNEXIS Announces First Participants Dosed in a Phase 1 Single Ascending Dose and Multiple Ascending Dose Trial of Intravenous SCY-247
February 26, 2026
·
3 min read
Press Releases
AbbVie Announces Positive Topline Results from a Phase 1 Multiple Ascending Dose Study of ABBV-295, a Long-Acting Amylin Analog, in Adults
March 9, 2026
·
6 min read
Press Releases
Crescent Biopharma Announces First Patient Dosed in ASCEND Phase 1/2 Clinical Trial of CR-001 for the Treatment of Advanced Solid Tumors
February 18, 2026
·
7 min read
Press Releases
BenchSci Extends ASCEND Agreement with Merck to Support Preclinical Disease Biology Research
December 10, 2025
·
2 min read
Press Releases
DemeRx Announces Successful Completion of Multiple Ascending Dose Clinical Trial of DMX-1001 for the Treatment of Alcohol Use Disorder (AUD)
January 6, 2026
·
3 min read
Press Releases
Onco3R Therapeutics Announces Completion of First Multiple Ascending Dose Cohort in Phase 1 Trial of Novel SIK3 inhibitor O3R-5671
December 3, 2025
·
4 min read
Press Releases
SCYNEXIS Announces Positive Results from a Phase 1, Single Ascending Dose and Multiple Ascending Dose Study of its Second-Generation Fungerp (SCY-247)
October 1, 2025
·
4 min read
Press Releases
Vivex Biologics, Inc. Completes Subject Enrollment for its ASCEND Trial Evaluating VIA Disc NP™ for Symptomatic Disc Degeneration
July 30, 2025
·
2 min read
Press Releases
European Patent on Ascend Advanced Therapies’ EpyQ® AAV Plasmid Technology Successfully Defended at the EPO
October 9, 2025
·
2 min read
1 of 74,525
Next
